Blood plasma is an essential resource in the production of life-saving medicines and are in high demand on the global markets. To make more efficient use of this valuable commodity, Biotest AG developed a new large-scale plant for plasma fractionation. Standardised components from Festo simplify installation and maintenance.
In order to be able to make the best possible use of this valuable raw material, companies like Biotest AG, based in Dreieich near Frankfurt/Main, Germany, are investing in research and innovative manufacturing methods for more efficient processes. This is also achieved through improved process automation. 6,000 valves and 250 standard-ised control cabinets from Festo simplify the construction and maintenance of the plants.